Topics

GSK, Lyell collaborate to develop new tech for cancer cell therapies

05:40 EDT 10 Oct 2019 | SmartBrief

GlaxoSmithKline and Lyell Immunopharma have partnered in a five-year deal to create novel technologies to enhance cancer cell -More

Original Article: GSK, Lyell collaborate to develop new tech for cancer cell therapies

NEXT ARTICLE

More From BioPortfolio on "GSK, Lyell collaborate to develop new tech for cancer cell therapies"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...